Misinfo Radar
Signals worth a closer look: weak sources, fact-checks, state media, copy-paste campaigns.
Revised prices on anti-cancer medicines effective from Monday, estimated annual savings of over ₹3500 crore
Left 100%100%
Attention level: Low (1 source)
- Headline mismatch 1 of 1 confidence: low
Articles whose headline says something its own description does not.
- The Hindu: Revised prices on anti-cancer medicines effective from Monday, estimated annual savings of over ₹3500 crore
About 1000 brands show reduction in prices; 203 remain unchanged
- The Hindu: Revised prices on anti-cancer medicines effective from Monday, estimated annual savings of over ₹3500 crore
Every outlet on this story
| Outlet | Lean | Reliability | Country | Articles |
|---|---|---|---|---|
| The Hindu | Leans left | 80 High | IN | 1 |
How this was worked out
The radar does not decide what is true. It lists signals that deserve a closer look, each with its evidence: who covers the story and how they are rated, matching fact-checks, state media, copy-paste campaigns, and headlines that are sensational or do not match their own description.
How INDB scores stories · Data: stories INDB grouped from the outlets on the sources page.